Annotation Detail for RUSC1
Basic Information
Top
Pathway ID | Pathway Name |
---|
200182 | Trk receptor signaling mediated by the MAPK pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RUSC1 mRNA | affects expression | 17562736
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of RUSC1 mRNA | decreases expression | 20106945
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of RUSC1 mRNA | increases expression | 18301758
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.64 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.22 | 16434500 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.71 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.39 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.63 | 19483382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.41 | 3084413 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.81 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.82 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.86 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.86 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.59 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
1.68 | 19370779 15619225 10774834 15968718 17562736 19085960 12153990 19164858 11743745 12705907 14725611 10915739 19739265 17522070 16781746 16227642 19416960 16081117 10663392 12958197 14550746 18071297 11529661 12594235 18713872 2444490 11461765 16109766 16485898 14986274 11739529 19420014 12540782 17906064 16393943 11421492 12392966 19923254 11287661 16177239 11834606 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.96 | 19426721 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.96 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.21 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.21 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12168785 12639820 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.54 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.78 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.64 | 16221962 19772884 18467677 19176532 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
3.06 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.63 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.90 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.55 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.55 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.12 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.71 | 11587558 16611625 19014921 19784758 19460945 12969438 16610002 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.68 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.94 | 20007298 16377806 15890375 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.22 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.16 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.29 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.29 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.12 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 18481113 19348381 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.26 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.89 | 20558911 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.77 | 16870215 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.64 | 12371664 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.56 | 19058328 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.50 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |